COVID-19 Rapid Manufacturing Capabilities – LEARN MORE

You are here

  1. Home
  2. Resources
  3. White Papers
  4. Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination

Why move to a low coefficient of friction thermoplastic elastomer?

Fluoropolymers have long been the reference for materials with good friction and wear properties.  Saint-Gobain recently launched a thermoplastic elastomer that demonstrates low coefficient of friction with great elastic properties. With the EPA and local municipalities closing a number of ethylene oxide (EtO) facilities there is added pressures on the supply chain for sterilization PTFE. Tygon® LCF has shown great ability to be irradiated by sterilization, which serves as a distinct advantage over fluoropolymers for many applications.

  • Material Overview
  • Comparison to traditional low CoF materials
  • Physical property highlights
  • Surface roughness comparison

Download our whitepaper to learn more about the novel low coefficient of friction thermoplastic elastomer. It gives medical device manufacturers a detailed comparison as to why Tygon® LCF is a good material choice for your project.

About Saint-Gobain

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in so many industrial applications.

 

Saint-Gobain Performance Plastics' group of businesses gather solutions to save energy, provide protection, improve comfort and sustain the environment for a variety of markets.

MENU

Capabilities
Materials
Markets
Resources
FAQs
About Us
Contact Us
Schedule a Lunch and Learn
Legal
CATSCA

 

 

 

FOLLOW US

 

 CONTACT US

Saint-Gobain’s medical products are distributed exclusively to medical device manufacturers for use in the manufacture, assembly or distribution of their medical devices. Saint-Gobain cannot authorize the sale of its medical products directly to device user facilities (e.g. hospitals, surgery centers, nursing home, clinics, etc.), nor directly to end users (e.g. patients, patients’ caregiver, prescribing physician, nurse, pharmacist, etc.), including distributors serving device user facilities and end users directly. In accordance with every jurisdiction globally, Saint-Gobain’s customers are responsible for determining that any medical device they manufacture and market that incorporates a Saint-Gobain’s medical product, is compliant with each country-specific medical device regulations and has received proper country-specific clearance, certification or registration authorizing the sale of this medical device.


Saint-Gobain’s medical products offer covers:
- Medical Components [21 CFR 820.3(c)], intended for processing or use in the manufacture or assembly of medical devices before the finished medical device is packaged/labeled; Medical Components are intended to be included as part of the finished, packaged, and labeled device [21CFR820.3(c)].
- Finished Devices [21CFR820.3(l)] made on behalf of medical device manufacturers [21 CFR 807.20(a)(2)] under contract-manufacturing agreement. In accordance with the United States’ jurisdiction, Saint-Gobain complies with the FDA’s requirements for contract manufacturers of finished devices.

© Copyright Saint-Gobain 2019. All rights reserved.